These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16444357)

  • 1. [Treatment of childhood adrenocortical tumor].
    Pereira RM; Michalkiewicz E; Pianovski MA; França SN; Boguszewski MC; Cat I; Lacerda Filho Ld; Sandrini R
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):747-52. PubMed ID: 16444357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression.
    Zancanella P; Pianovski MA; Oliveira BH; Ferman S; Piovezan GC; Lichtvan LL; Voss SZ; Stinghen ST; Callefe LG; Parise GA; Santana MH; Figueiredo BC
    J Pediatr Hematol Oncol; 2006 Aug; 28(8):513-24. PubMed ID: 16912591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
    Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
    Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol.
    Rodriguez-Galindo C; Krailo MD; Pinto EM; Pashankar F; Weldon CB; Huang L; Caran EM; Hicks J; McCarville MB; Malkin D; Wasserman JD; de Oliveira Filho AG; LaQuaglia MP; Ward DA; Zambetti G; Mastellaro MJ; Pappo AS; Ribeiro RC
    J Clin Oncol; 2021 Aug; 39(22):2463-2473. PubMed ID: 33822640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment for adrenocortical carcinoma].
    Iihara M; Obara T
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):342-5. PubMed ID: 15045937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update in adrenocortical carcinoma.
    Fassnacht M; Kroiss M; Allolio B
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4551-64. PubMed ID: 24081734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Case of Adrenocortical Carcinoma Successfully Treated with Multimodal Therapy].
    Bando S; Ishii G; Yamada H; Kimura T; Furuta N; Egawa S
    Hinyokika Kiyo; 2016 Jan; 62(1):15-9. PubMed ID: 26932330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
    Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
    Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case Report of a Patient with Metastatic Adrenocortical Carcinoma who Received the Combination Etoposide, Doxorubicin, Cisplatin, and Mitotane Therapy and Achieved Remission].
    Ueda S; Nakane K; Namiki S; Takeuchi Y; Kawase M; Takeuchi S; Kawase K; Nakai C; Kato D; Takai M; Iinuma K; Tsuchiya T; Miyazaki T; Koie T
    Hinyokika Kiyo; 2022 May; 68(5):139-143. PubMed ID: 35748231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic treatment of adrenocortical carcinoma in children: data from the German GPOH-MET 97 trial.
    Redlich A; Boxberger N; Strugala D; Frühwald MC; Leuschner I; Kropf S; Bucsky P; Vorwerk P
    Klin Padiatr; 2012 Oct; 224(6):366-71. PubMed ID: 23143764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocortical carcinoma in children: a role for etoposide and cisplatin adjuvant therapy? Preliminary report.
    Hovi L; Wikström S; Vettenranta K; Heikkilä P; Saarinen-Pihkala UM
    Med Pediatr Oncol; 2003 May; 40(5):324-6. PubMed ID: 12652623
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1-3 Adrenocortical Cancer After Surgery.
    Sarvestani AL; Gregory SN; Teke ME; Terzolo M; Berruti A; Hernandez JM; Habra MA
    Ann Surg Oncol; 2023 Feb; 30(2):680-682. PubMed ID: 36305989
    [No Abstract]   [Full Text] [Related]  

  • 13. [Three Cases of Advanced or Recurrent Adrenocortical Carcinoma Patients Treated with Etoposide, Doxorubicin and Cisplatin plus Mitotane].
    Sasaki S
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):67-70. PubMed ID: 29362311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocortical carcinoma.
    van Ditzhuijsen CI; van de Weijer R; Haak HR
    Neth J Med; 2007 Feb; 65(2):55-60. PubMed ID: 17379929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional chemotherapy and emerging targeted therapy for advanced adrenocortical carcinoma.
    Xu YZ; Zhu Y
    Anticancer Agents Med Chem; 2013 Feb; 13(2):248-53. PubMed ID: 22934700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.
    Williamson SK; Lew D; Miller GJ; Balcerzak SP; Baker LH; Crawford ED
    Cancer; 2000 Mar; 88(5):1159-65. PubMed ID: 10699907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adrenocortical carcinomas: therapeutic advances in 2011].
    Grunenwald S; Caron P
    Ann Endocrinol (Paris); 2011 Oct; 72 Suppl 1():S8-S14. PubMed ID: 22008276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant mitotane in adrenocortical carcinoma.
    Dickstein G; Shechner C; Nativ O
    N Engl J Med; 2007 Sep; 357(12):1257-8; author reply 1259. PubMed ID: 17891838
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of adrenal cortical carcinoma].
    Oida T; Souma T; Doi H; Hida S; Takasu K
    Hinyokika Kiyo; 2002 Nov; 48(11):667-70. PubMed ID: 12512139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant mitotane in adrenocortical carcinoma.
    Lee JE
    N Engl J Med; 2007 Sep; 357(12):1258; author reply 1259. PubMed ID: 17891836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.